Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
22
Sep |
Fuisz Announces Further Advances In Drug Compliance Verification For OpioidsCategory: Compliance | Leave a Comment |
Fuisz Pharma announced several advances in pharmaceutical compliance diagnostic systems, primarily directed at Opioids but also applicable to other drug classes. First, Fuisz placed its recent acquisition of the dominant, issued patent concerning the use of dyes and stains to demonstrate opioid misuse, within the larger context of Fuisz’s compliance system…
|
2
Apr |
PRISYM ID’s Medica Greatly Simplifies FDA And MHRA ComplianceCategory: Compliance | Leave a Comment |
PRISYM ID Limited announced the launch of a new product that allows life science companies to review, validate and record their product labels quickly and efficiently while allowing greater collaboration across the process…
|
9
Oct |
University Of Montreal Students Design Argus, A High-tech Pill Organizer - Could Help Save Lives And MoneyCategory: Compliance | Leave a Comment |
A new high-tech pill organizer designed by two students could help save lives and billions of dollars to the health-care system. According to Statistics Canada, 50 percent of Canadians don’t follow their prescriptions. As a result, one out of 10 patients ends up in the emergency room. This problem can have lethal consequences on the health of a patient and contributes to the blockage of ERs across the country.
|
8
Oct |
Compliance For Life™ Medication Dosing Reminders Go GlobalCategory: Compliance | Leave a Comment |
Compliance for Life™ is going global. iReminder, LLC, announces that Compliance for Life now delivers dosing reminders anywhere in the world by phone and SMS text message, as well as email.